Study to Evaluate the Safety and Efficacy of HLBLS-200 in Patients Requiring Hemostatic Technique
Clinical trial NCT03957356 · COMPLETED
Trial details
- NCT number
- NCT03957356
- Sponsor
- HLB Cell Co., Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-19
- Primary completion
- 2020-03-02
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.